Epidermal growth factor receptor mutations in non-small cell lung cancer: Predicting clinical response to kinase inhibitors

被引：19
|
作者：
Sequist, LV [1 ]
Haber, DA [1 ]
Lynch, TJ [1 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 16期
关键词：
D O I：
10.1158/1078-0432.CCR-05-1055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5668 / 5670
页数：3
相关论文
共 50 条
  • [21] Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
    Jaenne, Pasi A.
    Johnson, Bruce E.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4416S - 4420S
  • [22] EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER
    Kilickap, Saadettin
    [J]. NOBEL MEDICUS, 2018, 14 (03): : 5 - 8
  • [23] Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
    Lourdes, Laura S.
    Jalal, Shadia I.
    Hanna, Nasser
    [J]. ONCOLOGIST, 2015, 20 (09): : 975 - 978
  • [24] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [25] Third-Generation Tyrosine Kinase inhibitors Targeting epidermal Growth Factor Receptor Mutations in non-Small Cell Lung Cancer
    Barnes, Tristan A.
    O'Kane, Grainne M.
    Vincent, Mark David
    Leighl, Natasha B.
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [26] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer
    Zaarour, Mazen
    Weerasinghe, Chanudi
    Nazha, Bassel
    Hassan, Samer
    Atallah, Jean-Paul
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1327 - 1336
  • [27] Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Iwama, Eiji
    Nakanishi, Yoichi
    Okamoto, Isamu
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 267 - 276
  • [28] Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors
    Nurwidya, Fariz
    Takahashi, Fumiyuki
    Murakami, Akiko
    Kobayashi, Isao
    Kato, Motoyasu
    Shukuya, Takehito
    Tajima, Ken
    Shimada, Naoko
    Takahashi, Kazuhisa
    [J]. RESPIRATORY INVESTIGATION, 2014, 52 (02) : 82 - 91
  • [29] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Non-Small Cell Lung Cancer With Uncommon Mutations
    Kanazu, Masaki
    Naoki, Yoko
    Shiroyama, Takayuki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Omachi, Naoki
    Okishio, Kyoichi
    Suzuki, Hidekazu
    Okamoto, Norio
    Morishita, Naoko
    Hirashima, Tomonori
    Atagi, Shinji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [30] Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
    Tan, Chee-Seng
    Cho, Byoung-Chul
    Soo, Ross A.
    [J]. LUNG CANCER, 2016, 93 : 59 - 68
12345